EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC 4.0

A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)

Adam Femerling Langhoff, Niklas Dyrby Johansen, Marie Frimodt-Møller, Ahmad Sajadieh, Tina Ken Schramm, Thomas A Jepps, Tor Biering-Sørensen

The Journal of Clinical Hypertension · 2026-06 · 28 (6)

DOI: 10.1111/jch.70296 ↗

At a glance

Randomisierte kontrollierte Studie in The Journal of Clinical Hypertension, published online on 2026-05-28. Written by Adam Femerling Langhoff and 6 co-authors. Institution: Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. Major MEDLINE topics: Colchicine, Hypertension. 32 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Novo Nordisk Foundation, Lundbeck Foundation, Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hypertension is a prevalent and significant risk factor for cardiovascular disease (CVD). The immune system and inflammatory response are involved in the pathophysiology of hypertension. We hypothesize that treating hypertension with colchicine on top of standard therapy, will decrease pulse wave velocity (PWV), left ventricular mass, cardiac/inflammatory biomarkers. COHERENT was an investigator‐initiated, single‐center, prospective, randomized, double‐blind, placebo‐controlled study of the effects of colchicine in patients with hypertension. Potential participants were identified through nationwide health registries. Eligible patients were randomized 1:1 to colchicine 0.5 mg daily or placebo and treated for 6 months. Assessment of vascular function, echocardiography, and measurement of biomarkers were performed at baseline and at 6 months. The primary endpoint of the trial was change from baseline in carotid‐femoral PWV at 6 months. Secondary endpoints included blood pressure, echocardiographic measurements, and cardiac/inflammatory biomarkers. We screened 183 potential participants, of whom 150 were randomized from August 2021 to July 2025. A total of 75 (50%) were assigned to receive colchicine. Participants had a mean age of 64.5 years (SD 8.0) and 53 (35%) were female, 82 (55%) were active or former smokers, mean systolic blood pressure was 140 mmHg (SD 16.5), mean diastolic pressure was 86 mmHg (10.5), and median high sensitivity C‐reactive protein was 0.97 mg/L (IQR: 0.52–2.05). COHERENT is the first trial to investigate the effects of colchicine in patients with hypertension without other known CVD. The trial will provide important data on whether anti‐inflammatory therapy should be considered for patients with hypertension. Clinical Trial registration : Clinicaltrials.gov: NCT04916522, registered June 3, 2021, https://clinicaltrials.gov/study/NCT04916522 Practical Applications COHERENT has the potential to determine whether colchicine can modulate pathological processes in hypertension, such as increased arterial stiffness and blood pressure. If the trial outcome is positive, it could impact therapy for millions of hypertensive patients. Since the socio‐economic costs of therapy and care related to hypertension and heart disease are enormous, the results from the study may also be important at a broader societal level, given that colchicine is relatively inexpensive, already approved for treatment in patients following myocardial infarction, and widely considered safe to use with an acceptable low level of side effects when used in low doses. Furthermore, this study can help elucidate the pathophysiological pathways from early‐stage cardiovascular disease ‐ where only hypertension is present ‐ and determine whether anti‐inflammatory therapy such as colchicine can help prevent deleterious vascular function changes and potentially prevent progression to overt cardiovascular disease.

Subjects

MeSH terms (MEDLINE)

ColchicineHypertensionHumansFemaleMiddle AgedMaleDouble-Blind MethodPulse Wave AnalysisProspective StudiesEchocardiographyAgedBlood PressureBiomarkersTreatment OutcomeCardiovascular DiseasesVascular Stiffness

Author keywords

cardiovascular diseaseechocardiographyhypertensioninflammationpulse wave velocity

Substances

ColchicineBiomarkers

Authors and institutions

  • Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
  • Center For Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Nephrology, Copenhagen University Hospital- Herlev and Gentofte, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Funding

  • Novo Nordisk Foundation
  • Lundbeck Foundation
  • Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond
  • Novo Nordisk Fonden

Cite

APA

Langhoff, A. F., Johansen, N. D., Frimodt-Møller, M., Sajadieh, A., Schramm, T. K., Jepps, T. A., & Biering-Sørensen, T. (2026). A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT). The Journal of Clinical Hypertension, 28(6). https://doi.org/10.1111/jch.70296

Vancouver

Langhoff AF, Johansen ND, Frimodt-Møller M, Sajadieh A, Schramm TK, Jepps TA, et al. A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT). The Journal of Clinical Hypertension. 2026;28(6). doi:10.1111/jch.70296

BibTeX
@article{Langhoff2026,
  author = {Langhoff, Adam Femerling and Johansen, Niklas Dyrby and Frimodt-Møller, Marie and Sajadieh, Ahmad and Schramm, Tina Ken and Jepps, Thomas A and Biering-Sørensen, Tor},
  title = {A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)},
  journal = {The Journal of Clinical Hypertension},
  year = {2026},
  volume = {28},
  number = {6},
  doi = {10.1111/jch.70296}
}
Start for free →